{'fraction_non_alphanumeric': 0.026183282980866064, 'fraction_numerical': 0.02416918429003021, 'mean_word_length': 5.454545454545454, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A cost containment program targeting home infusion drug therapy.

A program was instituted to determine if retrospective, concurrent, and prospective analysis of home infusion therapy cases by a multidisciplinary team comprising clinicians and financial analysts would lead to cost reductions and cost-effective behavioral changes by providers. Actual invoices and prospective price quotes for infusion therapy were reviewed and compared to a database of "usual and customary" prices. The results were presented to providers with the intent of obtaining a reduction in prices for the services rendered or about to be rendered. As a result, $3,265,248 in short-term cost reductions were achieved, and $15,146,789 in long-term cost reductions are projected. Analysis resulted in average cost reductions of $2,247 and $10,424 respectively. Very significant cost reductions can be achieved through the use of a multidisciplinary team and a comprehensive pricing database for home infusion therapy.